How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018

被引：0
|
作者：
A. J. W. M. de Veer
N. Bennaghmouch
W. J. M. Dewilde
J. M. ten Berg
机构：
[1] St. Antonius Hospital,Department of Cardiology
[2] Imelda Hospital,Department of Cardiology
来源：
Netherlands Heart Journal | 2021年 / 29卷
关键词：
Anticoagulation; Antiplatelet therapy; Acute coronary syndrome; Percutaneous coronary intervention; Atrial fibrillation; Non-vitamin K antagonist oral anticoagulants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 141
页数：6
相关论文
共 50 条
  • [1] How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
    de Veer, A. J. W. M.
    Bennaghmouch, N.
    Dewilde, W. J. M.
    ten Berg, J. M.
    NETHERLANDS HEART JOURNAL, 2021, 29 (03) : 135 - 141
  • [2] The Optimal Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention With Stenting
    Iwasaki, Yusuke
    Fukunami, Masatake
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takasi
    Sanada, Shoji
    Furukawa, Yoshio
    Masuda, Masaharu
    Yasui, Taku
    Ueda, Hiromichi
    Okada, Takeshi
    Kawasaki, Masato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A429 - A429
  • [3] The Antithrombotic Treatment of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Bezzina, E.
    Bucci, C.
    Diamantouros, A.
    Radhakrishnan, S.
    Ahmed, S.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (01): : 77 - 77
  • [4] The WOEST 2 registryA prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
    A. J. W. M. de Veer
    N. Bennaghmouch
    W. L. Bor
    J. P. R. Herrman
    M. Vrolix
    M. Meuwissen
    T. Vandendriessche
    T. Adriaenssens
    B. de Bruyne
    M. Magro
    W. J. M Dewilde
    J. M. ten Berg
    Netherlands Heart Journal, 2022, 30 : 302 - 311
  • [5] The WOEST 2 registry A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
    de Veer, A. J. W. M.
    Bennaghmouch, N.
    Bor, W. L.
    Herrman, J. P. R.
    Vrolix, M.
    Meuwissen, M.
    Vandendriessche, T.
    Adriaenssens, T.
    de Bruyne, B.
    Magro, M.
    Dewilde, W. J. M.
    Ten Berg, J. M.
    NETHERLANDS HEART JOURNAL, 2022, 30 (06) : 302 - 311
  • [6] Evolving Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From a Survey Among US Cardiologists
    Vardi, Moshe
    Debidda, Marcella
    Bhatt, Deepak L.
    Mauri, Laura
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2014, 37 (02) : 103 - 107
  • [7] Antithrombotic treatment in anticoagulated atrial fibrillation patients undergoing percutaneous coronary intervention
    Dezsi, Csaba Andras
    Dezsi, Balazs Bence
    Dezsi, Dome Andras
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 40 : 1 - 7
  • [8] Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting
    Lacoste, Jordan L.
    Hansen, Cory L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (18) : 1395 - 1402
  • [9] Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Camaj, Anton
    Miller, Michael S.
    Halperin, Jonathan L.
    Giustino, Gennaro
    CARDIOLOGY CLINICS, 2020, 38 (04) : 551 - 561
  • [10] Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Panov, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (04) : 628 - 637
12345